Enovis CORP financial data

Symbol
ENOV on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
2711 Centerville Road, Suite 400, Wilmington, DE
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Colfax CORP (to 3/18/2022)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 227 % +36.9%
Quick Ratio 119 % +46%
Debt-to-equity 47.3 % +75.5%
Return On Equity -2.69 % +33.3%
Return On Assets -1.83 % +42.5%
Operating Margin -5.51 % -4.75%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.9M shares +2.4%
Common Stock, Shares, Outstanding 54.9M shares +0.61%
Entity Public Float 3.48B USD +29.6%
Common Stock, Value, Issued 55K USD 0%
Weighted Average Number of Shares Outstanding, Basic 54.9M shares +0.63%
Weighted Average Number of Shares Outstanding, Diluted 54.9M shares +0.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.02B USD +16.4%
Revenue from Contract with Customer, Excluding Assessed Tax 1.91B USD +17.6%
Research and Development Expense 85.1M USD +26.2%
Operating Income (Loss) -105M USD -23.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -124M USD +4.35%
Income Tax Expense (Benefit) -17.8M USD -163%
Net Income (Loss) Attributable to Parent -90.6M USD +34.6%
Earnings Per Share, Basic -0.34 USD/shares -88.9%
Earnings Per Share, Diluted -1.66 USD/shares +34.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35M USD +7.73%
Accounts Receivable, after Allowance for Credit Loss, Current 395M USD +32%
Inventory, Net 615M USD +35.5%
Other Assets, Current 87.4M USD +16.4%
Assets, Current 1.17B USD +32.2%
Property, Plant and Equipment, Net 378M USD +45.1%
Operating Lease, Right-of-Use Asset 68.2M USD +10.5%
Intangible Assets, Net (Excluding Goodwill) 1.38B USD +24.3%
Goodwill 2.35B USD +15.7%
Other Assets, Noncurrent 88.6M USD -0.15%
Assets 5.44B USD +22.5%
Accounts Payable, Current 160M USD +8.6%
Employee-related Liabilities, Current 95.4M USD +80.5%
Accrued Liabilities, Current 343M USD +66.2%
Liabilities, Current 518M USD +46.5%
Other Liabilities, Noncurrent 255M USD +33.2%
Liabilities 2.15B USD +117%
Accumulated Other Comprehensive Income (Loss), Net of Tax -76.7M USD -102%
Retained Earnings (Accumulated Deficit) 452M USD -16.7%
Stockholders' Equity Attributable to Parent 3.29B USD -4.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.29B USD -4.69%
Liabilities and Equity 5.44B USD +22.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.2M USD -585%
Net Cash Provided by (Used in) Financing Activities 865M USD +3429%
Net Cash Provided by (Used in) Investing Activities -798M USD -2220%
Common Stock, Shares Authorized 133M shares 0%
Common Stock, Shares, Issued 54.9M shares +0.61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.7M USD
Deferred Tax Assets, Valuation Allowance 102M USD +8.67%
Operating Lease, Liability 66.2M USD -4.62%
Payments to Acquire Property, Plant, and Equipment 36.9M USD +21.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -129M USD -47.8%
Lessee, Operating Lease, Liability, to be Paid 71.7M USD -5.56%
Property, Plant and Equipment, Gross 513M USD +22.8%
Operating Lease, Liability, Current 4.34M USD -80.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.4M USD +7.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.5M USD -12.6%
Deferred Income Tax Expense (Benefit) -9.97M USD -1299%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.51M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.4M USD +6.43%
Deferred Tax Assets, Operating Loss Carryforwards 37.4M USD -1.39%
Unrecognized Tax Benefits 32.1M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.4M USD -18.6%
Additional Paid in Capital 2.91B USD -1.12%
Amortization of Intangible Assets 151M USD +18.1%
Depreciation, Depletion and Amortization 6.43M USD -15.4%
Deferred Tax Assets, Net of Valuation Allowance 227M USD +2.25%
Share-based Payment Arrangement, Expense 30.3M USD -7.32%
Interest Expense 47M USD +112%